Olaratumab

From Self-sufficiency
Jump to: navigation, search
Olaratumab
Monoclonal antibody
Type Whole antibody
Source Template:Infobox drug/mab source
Target PDGF-R α
Legal status
Legal status
  • investigational
Identifiers
CAS Number 1024603-93-7
ATC code none
Chemical data
Formula C6554H10076N1736O2048S40
Molar mass 147.2 kDa[[Script error: No such module "String".]]
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Olaratumab is a monoclonal antibody which is being developed by Imclone for the treatment of solid tumors. It is directed against the platelet-derived growth factor receptor alpha.[1]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />
  1. Statement on a Nonproprietary name adopted by the USAN Council: Olaratumab